Food chemistry , 329 , 127188
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial
External resources GLP-1 Receptor Agonists: Beyond Glycemic Control (Nature Reviews Endocrinology) Understanding Obesity: Causes, Consequences, and Treatment (The Obesity Society) And if you have made it this far, in case nobody has told you lately, good morning, and in case I do not see you, good afternoon, good evening, and good night
modest improvements in LDL and HDL ratios Liver health: Significant improvements in non-alcoholic fatty liver disease (NAFLD), an increasingly common obesity-related condition Sleep apnea: The SURMOUNT-OSA trial showed tirzepatide reduced sleep apnea severity by up to 63% Joint health: Weight reduction directly reduces mechanical load on hips, knees, and ankles reducing pain and improving mobility Ready to Find Out If GLP-1 Medication Is Right for You
Certain presentations require immediate emergency care, while others may be appropriate for timely outpatient assessment
Experts from UT Southwestern, University of Colorado, Cato Institute, and Obesity Action Coalition share what evidence currently shows about GLP-1 function and effectiveness and discuss how to ensure patient access, affordability, and safety
